John Fowler Named COO of Piramal Pharma Solutions

10:24 EDT 14 Sep 2017 | CHEManager

Piramal Pharma Solutions (PPS) has appointed John Fowler as its Chief Operating Officer (COO). PPS is a leader in Integrated Contract Development and Manufacturing, with a global network of 12 development and manufacturing facilities across North America, Europe and Asia. PPS offers a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies and Commercial supply of APIs and Finished dosage forms.

Original Article: John Fowler Named COO of Piramal Pharma Solutions


More From BioPortfolio on "John Fowler Named COO of Piramal Pharma Solutions"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...